Research Article
EUS Morphology Is Reliable in Selecting Patients with Mucinous Pancreatic Cyst(s) Most Likely to Benefit from Surgical Resection
Table 1
Comparison between patients with surgery data available and patients who did not have surgery or surgery data not available.
| | Indication for surgery | Patients who had surgery data
| Patients who did not have surgery or no surgery data available
|
| | Size ≥ 3 cm | 42 (53.8%) | 45 (58.4%) | | Focal wall thickness | 49 (62.8%) | 33 (42.8%) | | Thickened septa | 25 (32.1%) | 14 (18.2%) | | Atypia/adenocarcinoma | 39 (50%) | 33(42.8%) | | Atypia | 19 (25.6%) | 11 (14.3%) | | Adenocarcinoma | 20 (25.4%) | 22 (28.6%) | | CEA > 500 | 32 (41%) | 11 (14.3%) | | PD dilation | 22(28.2%) | 25(32.5%) | | People with only 1 indication for surgery | | N | 20 (25.6%) | 40 (51.9%) | | Size ≥ 3 cm | 7 (9%) | 21 (27.3%) | | Focal wall thickness | 1 | 4 (5.2%) | | Thickened septa | 0 | 1 | | Atypia/adenocarcinoma | 3 (3.8%) | 3 (3.9%) | | CEA > 500 | 9 (11.5%) | 11 (14.3%) |
|
|
Adenocarcinoma includes pts with adenocarcinoma and high grade atypia noted on cytology. CEA: carcinoembryonic antigen; PD: pancreatic duct.
|
